Table 1.
Baseline characteristics of patients with polycystic ovary syndrome randomized to moderate and vigorous exercise interventions.
| Patient characteristics | Moderate (n = 11) Mean ± SD or n (%) |
Vigorous (n = 9) Mean ± SD or n (%) |
P valuea |
|---|---|---|---|
| Age (y) | 30.1 ± 6.3 | 32.4 ± 5.3 | .40 |
| BMI (kg/m2) | 32.6 ± 7.5 | 33.7 ± 6.3 | .74 |
| Beck Depression Inventory score | 5.9 ± 4.7 | 5.3 ± 4.6 | .79 |
| Total cholesterol (mg/dL) | 189.9 ± 23.7 | 197.9 ± 31.7 | .57 |
| HDL (mg/dL) | 59.3 ± 11.3 | 48.9 ± 9.3 | .07 |
| Triglycerides (mg/dL) | 125.8 ± 60.1 | 128.7 ± 36.3 | .91 |
| 2-h insulin (mIU/mL) | 117.8 ± 88 | 151 ± 124.4 | .56 |
| 2-h glucose (mg/dL) | 113.2 ± 34.4 | 115.5 ± 23.5 | .89 |
| MFG score | 13 ± 9 | 10 ± 6 | .50 |
| DHEAS (mg/dL) | 372.6 ± 229.7 | 263.2 ± 134.3 | .33 |
| Androstenedione (ng/dL) | 266.1 ± 108.2 | 124.5 ± 147.3 | .08 |
| Total testosterone (ng/dL) | 50.4 ± 24.5 | 52.4 ± 25.1 | .89 |
| Free testosterone (pg/mL) | 8.3 ± 7.2 | 5.2 ± 2.8 | .38 |
| SHBG (nmol/L) | 28.7 ± 16.6 | 73.2 ± 103.9 | .39 |
| FNPO | 22.9 ± 6.05 | 26.1 ± 13.8 | .59 |
| Ovarian volume (cc) | 10.8 ± 5.3 | 6.8±4.7 | .18 |
| Oligoanovulation | 6 (75.0) | 4 (66.7) | .73 |
| PCOM | 7 (100) | 4 (66.7) | .10 |
| Clinical or biochemical HA | 7 (87.5) | 6 (100) | .37 |
Notes: BMI = body mass index; DHEAS = dehydroepiandrosterone sulfate; FNPO = follicle number per ovary; HA = hyperandrogenism; HDL = high-density lipoprotein; mFG = modified Ferriman-Gallwey; PCOM = polycystic ovarian morphology; SHBG = sex hormone binding globulin.
a
P value derived from an independent sample t-test or the Mann-Whitney U test for continuous variables and the chi-square test for categorical variables.